BlackRock Health Sciences Trust (NYSE:BME) Shares Cross Above 50-Day Moving Average – Should You Sell?

BlackRock Health Sciences Trust (NYSE:BME)’s stock price crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $41.87 and traded as high as $43.71. BlackRock Health Sciences Trust shares last traded at $43.43, with a volume of 46,927 shares.

BlackRock Health Sciences Trust Stock Up 0.6%

The stock’s fifty day moving average price is $41.87 and its 200-day moving average price is $40.89.

BlackRock Health Sciences Trust Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be paid a dividend of $0.2621 per share. This represents a c) dividend on an annualized basis and a dividend yield of 7.2%. The ex-dividend date is Tuesday, September 15th.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Northwestern Mutual Wealth Management Co. raised its position in BlackRock Health Sciences Trust by 285,436.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 4,046,055 shares of the company’s stock worth $166,414,000 after acquiring an additional 4,044,638 shares in the last quarter. 1607 Capital Partners LLC grew its position in shares of BlackRock Health Sciences Trust by 49.5% in the 4th quarter. 1607 Capital Partners LLC now owns 229,260 shares of the company’s stock valued at $9,429,000 after acquiring an additional 75,958 shares during the period. Bank of America Corp DE grew its position in shares of BlackRock Health Sciences Trust by 18.8% in the 3rd quarter. Bank of America Corp DE now owns 216,404 shares of the company’s stock valued at $8,057,000 after acquiring an additional 34,218 shares during the period. Royal Bank of Canada increased its stake in shares of BlackRock Health Sciences Trust by 13.0% during the 4th quarter. Royal Bank of Canada now owns 160,464 shares of the company’s stock worth $6,600,000 after purchasing an additional 18,442 shares during the last quarter. Finally, Invesco Ltd. increased its stake in shares of BlackRock Health Sciences Trust by 7.6% during the 3rd quarter. Invesco Ltd. now owns 217,169 shares of the company’s stock worth $8,085,000 after purchasing an additional 15,381 shares during the last quarter.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.